-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bv5T5Imfv/6mrzEev26yGJfIMTKfXDC0LSR9I4ACx1F2evSCdk0Phnf7prvFBkPN S+ZB4bZG+XG5fb4loEhXRA== 0001246360-10-002867.txt : 20100803 0001246360-10-002867.hdr.sgml : 20100803 20100803161236 ACCESSION NUMBER: 0001246360-10-002867 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100731 FILED AS OF DATE: 20100803 DATE AS OF CHANGE: 20100803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kuntz Richard CENTRAL INDEX KEY: 0001341125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 10987778 MAIL ADDRESS: STREET 1: MEDTRONIC, INC. STREET 2: 710 MEDTRONIC PWKY MS LC 310 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 form.xml PRIMARY DOCUMENT X0303 4 2010-07-31 false 0000064670 MEDTRONIC INC MDT 0001341125 Kuntz Richard 710 MEDTRONIC PKWY MS LC310 MINNEAPOLIS MN 55432 false true false false SrVP & Chief Scien, Clin, Reg Common Stock 2010-07-31 4 F false 446 36.97 D 89921.484 D Common Stock 2010-08-02 4 A false 8900 0 A 98821.484 D Employee Stock Option (right to buy) 37.53 2010-08-02 4 A false 35492 0 A 2011-08-02 2020-08-02 Common Stock 35492 35492 D This balance has increased by 1705.497 due to exempt transactons such as dividend reinvestment and dividend equivalent credits. The restrictions on these restricted stock units shall lapse on the third anniversary of the grant date if the company's cumulative diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2013 equals or exceeds a 5% compound annual growth rate, as determined by the Compensation Committee. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Rhonda L. Ingalsbe, Attorney-in-fact 2010-08-03 -----END PRIVACY-ENHANCED MESSAGE-----